Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome

Neurology

Volumn 76, Issue 17, 2011, Pages 1508-1513

  Brilot, F ^a   Merheb, V ^a   Ding, A ^a   Murphy, T ^b   Dale, R C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL SURFACE PROTEIN; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL SURFACE; CHILD; CHOREA MINOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; NERVE CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 79955517034     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182181090     Document Type: Article

References (21)

1. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenhams chorea. Neurology 2002;59:227-231. (Pubitemid 34779182)
2. Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenhams chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol 2005;20:424-429. (Pubitemid 40873048)
3. Kirvan CA, Swedo SE, Kurahara D, Cunningham MW. Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenhams chorea. Autoimmunity 2006;39:21-29. (Pubitemid 43878517)
4. Kirvan CA, Swedo SE, Snider LA, Cunningham MW. Antibody-mediated neuronal cell signaling in behavior and movement disorders. J Neuroimmunol 2006;179:173-179. (Pubitemid 44472532)
5. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271. (Pubitemid 28074291)
6. Dale RC, Candler PM, Church AJ, Wait R, Pocock JM, Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. J Neuroimmunol 2006;172:187-197. (Pubitemid 43277505)
7. Husby G, van de Rijn I, Zabriskie JB, Abdin ZH, Williams RC Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976;144:1094-1110.
8. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-920. (Pubitemid 36889935)
9. Singer HS, Hong JJ, Yoon DY, Williams PN. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005;65:1701-1707.
10. Church AJ, Dale RC, Lees AJ, Giovannoni G, Robertson MM. Tourettes syndrome: a cross sectional study to examine the PANDAS hypothesis. J Neurol Neurosurg Psychiatry 2003;74:602-607.
11. Pavone P, Parano E, Rizzo R, Trifiletti RR. Autoimmune neuropsychiatric disorders associated with streptococcal infection: Sydenham chorea, PANDAS, and PANDAS variants. J Child Neurol 2006;21:727-736. (Pubitemid 44696718)
12. Morris CM, Pardo-Villamizar C, Gause CD, Singer HS. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci 2009;276:45-48.
13. Blaes F, Fuhlhuber V, Korfei M, et al. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 2005;58:313-317. (Pubitemid 41098889)
14. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-517.
15. Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology 2008;71:930-936.
16. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics 1998; 101:86-88. (Pubitemid 28030329)
17. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009;66:833-842.
18. Presgraves SP, Ahmed T, Borwege S, Joyce JN. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox Res 2004;5:579-598.
19. Kirvan CA, Cox CJ, Swedo SE, Cunningham MW. Tubulin is a neuronal target of autoantibodies in Sydenhams chorea. J Immunol 2007;178:7412-7421. (Pubitemid 46847469)
20. Kawikova I, Grady BP, Tobiasova Z, et al. Children with Tourettes syndrome may suffer immunoglobulin A dysgammaglobulinemia: preliminary report. Biol Psychiatry 2010;67:679-683.
21. Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. Immunopathogenic mechanisms in Tourette syndrome: a critical review. Mov Disord 2009;24:1267-1279.